US Patent Issued to PTC Therapeutics MP, Virginia Commonwealth University on June 30 for "Use of sepiapterin and metabolites thereof to treat radiation exposure" (Virginia, North Carolina Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,569, issued on June 30, was assigned to PTC Therapeutics MP Inc. (Warren, N.J.) and Virginia Commonwealth University (Richmond, Va.).

"Use of sepiapterin and metabolites thereof to treat radiation exposure" was invented by Eleonora Mezzaroma (Glen Allen, Va.), Christopher Rabender (Chesterfield, Va.), Ross Mikkelsen (Richmond, Va.), Vasily Yakovlev (Richmond, Va.) and Neil Smith (Cary, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides methods for treating radiation exposure in a subject by administering sepiapterin, tetrahydrobiopterin, or dihydrobiopterin."

The patent was filed on Aug. 5, 2020, under Application No. 17/631...